Skip to main content
Virbac logo

Virbac — Investor Relations & Filings

Ticker · FR000 ISIN · FR0000031577 LEI · 969500QQ1X5XHG649644 PA Manufacturing
Open in API
Filings indexed 975 across all filing types
Latest filing 2014-08-29 Interim / Quarterly Rep…
Country FR France
Listing PA FR000

About Virbac

https://corporate.virbac.com/home.html

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.

Recent filings

Filing Released Lang Actions
Virbac : Half yearly financial report as of June 30, 2014
Interim / Quarterly Report Classification · 100% confidence The document is titled 'HALF YEARLY BUSINESS REPORT' and contains comprehensive financial statements, including a statement of financial position and an income statement for the period ending June 30, 2014. It provides a detailed review of financial performance, business segments, and geographic regions. Since it contains substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2014
2014-08-29 English
Declaration of the nb of shares and voting rights July 14
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled 'DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS' and explicitly references Article 223-16 of the French Financial Market Authority (AMF) regulations. It provides a table detailing the 'Total number of shares representing the share capital' and the 'Total number of voting rights' as of a specific date (July 31, 2014). This content directly relates to the official declaration of voting rights and share capital structure, which aligns precisely with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a declaration of rights rather than results of a vote, DVA is the most specific category available for this type of regulatory disclosure regarding voting rights structure.
2014-08-01 English
Déclaration d'actions et de droits de vote au 31 Juillet 2014
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration of Shares and Voting Rights) and explicitly references the total number of voting rights and shares outstanding as of a specific date (July 31, 2014). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official announcements related to voting rights and share capital structure relevant to shareholder meetings or regulatory disclosure. The document is short and contains the required regulatory disclosure information.
2014-08-01 French
VIRBAC : croissance organique de 3% au premier semestre
Earnings Release Classification · 98% confidence The document is a press release dated July 17, 2014, detailing the consolidated revenue for the second quarter and the first half of the year ("premier semestre"). It provides key financial highlights, performance analysis by region and segment, and outlook, but it is not the full, comprehensive annual report (10-K) or a detailed interim report (IR). The structure and content strongly align with an initial announcement of periodical financial results, focusing on key figures and commentary. Therefore, it is classified as an Earnings Release (ER). The document length (4159 chars) is consistent with a brief release rather than a full report. H1 2014
2014-07-17 French
Virbac : organic growth of 3% in the first quarter
Earnings Release Classification · 98% confidence The document is a public release dated July 17th, 2014, detailing consolidated sales figures for the second quarter and the first half of the year (Year-to-date). It provides key financial highlights, performance analysis by region and species, and future perspectives. This structure—a concise announcement of period-specific financial results—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim/Quarterly Report (IR), but rather the initial public announcement of the results. H1 2014
2014-07-17 English
Virbac : bilan semestriel contrat de liquidité au 30 juin 2014
Capital/Financing Update Classification · 99% confidence The document is titled "BILAN SEMESTRIEL DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE" (Semi-annual balance sheet of means allocated to the liquidity contract) and reports the status of a liquidity contract (market making agreement) as of June 30, 2014, comparing it to the previous balance on December 31, 2013. This type of regular update concerning market making activities, often related to share trading or liquidity provision, does not fit perfectly into the main financial report categories (10-K, IR). It is a specific regulatory or contractual disclosure related to market operations. Given the options, it is a specialized financial disclosure. Since it is a specific report on liquidity/market making balance, and not a general earnings release (ER) or a comprehensive interim report (IR), it falls best under the general 'Regulatory Filings' (RNS) as a specific, non-standard disclosure, or potentially 'Capital/Financing Update' (CAP) if the liquidity contract is viewed as a financing mechanism, but RNS is a safer fallback for specific contractual updates not covered elsewhere. However, upon re-evaluation, liquidity contracts are often related to share stabilization or trading, which is a specific operational disclosure. Given the highly specific nature and the lack of a dedicated 'Liquidity Contract Update' code, RNS is the most appropriate general regulatory filing category.
2014-07-08 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.